Libby P, Goldberg A L
J Cell Physiol. 1981 May;107(2):185-94. doi: 10.1002/jcp.1041070204.
In the studies reported here, we investigated whether the degradation of the acetylcholine receptor (AChR) in cultured muscle cells involves similar mechanisms as, and is controlled in a manner similar to, the catabolism of the bulk of cell protein. We compared these processes after labeling cell protein with radioactive leucine or phenylalanine for 24 hours, or labeling the acetylcholine receptor with (125I)-bungarotoxin. The apparent average half-life of cell protein was 38 +/- 2 hours and that of the receptor-toxin complex was 25 +/- 1 hours. Incubation in media lacking serum and embryo extract accelerated the degradation of both average protein and the receptor-toxin complex. Insulin reduced the rate of catabolism of both average protein and the receptor-toxin complex toward levels seen in the presence of serum. However, although these two degradative processes seem to be controlled similarly, they probably involve different mechanisms. The protease inhibitors leupeptin and chymostatin, which slowed overall proteolysis in nongrowing muscles and hepatocytes, reduced the degradation of the ACh receptor by 2--11-fold, but had no, or only slight, effects on the catabolism of average protein, even when overall proteolysis was accelerated by omitting serum and embryo extract. Chloroquine, an inhibitor of lysosomal function, also reduced the degradation of AChR, by about 10-fold, but decreased overall protein breakdown by only 20-30%. Incubation of myotubes at lower temperatures reduced both degradative processes, but affected the breakdown of the receptor to a greater extent. Thus the rate-limiting steps in these processes have different activation energies. Incubation with 2-deoxyglucose, an inhibitor of glycolysis, decreased the breakdown of average protein but not that of the receptor-toxin complex. However, the two degradative processes were sensitive to azide, an inhibitor of oxidative phosphorylation. Although the lysosome is the primary site for AChR degradation and perhaps for degradation of other surface proteins, the breakdown of most proteins in myotubes seems to involve a distinct proteolytic system requiring metabolic energy.
在本文报道的研究中,我们探究了培养的肌细胞中乙酰胆碱受体(AChR)的降解是否涉及与细胞大量蛋白质分解代谢相似的机制,以及其降解是否以类似的方式受到调控。我们在用放射性亮氨酸或苯丙氨酸标记细胞蛋白质24小时后,或者用(125I)-银环蛇毒素标记乙酰胆碱受体后,对这些过程进行了比较。细胞蛋白质的表观平均半衰期为38±2小时,受体-毒素复合物的表观平均半衰期为25±1小时。在缺乏血清和胚胎提取物的培养基中孵育会加速平均蛋白质和受体-毒素复合物的降解。胰岛素可将平均蛋白质和受体-毒素复合物的分解代谢速率降低至血清存在时的水平。然而,尽管这两个降解过程似乎受到类似的调控,但它们可能涉及不同的机制。蛋白酶抑制剂亮抑酶肽和抑肽酶可减缓非生长状态的肌肉和肝细胞中的整体蛋白水解,使ACh受体的降解降低2至11倍,但对平均蛋白质的分解代谢没有影响或仅有轻微影响,即使在通过省略血清和胚胎提取物加速整体蛋白水解时也是如此。溶酶体功能抑制剂氯喹也可使AChR的降解降低约10倍,但仅使整体蛋白质分解减少20%至30%。在较低温度下孵育肌管会降低这两个降解过程,但对受体分解的影响更大。因此,这些过程中的限速步骤具有不同的活化能。用糖酵解抑制剂2-脱氧葡萄糖孵育可降低平均蛋白质的分解,但不影响受体-毒素复合物的分解。然而,这两个降解过程对氧化磷酸化抑制剂叠氮化物敏感。尽管溶酶体是AChR降解以及可能是其他表面蛋白降解的主要场所,但肌管中大多数蛋白质的分解似乎涉及一个需要代谢能量的独特蛋白水解系统。